PDF(1142 KB)
Preliminary analysis of urinary proteomics in children with steroidresistant and steroidsensitive nephrotic syndrome
HUANG Ai-Wen, HE Qing-Nan, ZHOU Pin, DING Juan-Juan, YI Zhu-Wen
Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (05) : 341-345.
PDF(1142 KB)
PDF(1142 KB)
Preliminary analysis of urinary proteomics in children with steroidresistant and steroidsensitive nephrotic syndrome
OBJECTIVE: To study and identify the protein markers in the urine of children with steroid-sensitive (SSNS) and steroid-resistant nephrotic syndrome(SRNS). METHODS: Total urinary proteins were extracted from children with SSNS before and after steroid therapy, SRNS, and healthy children (n=5 in each group). Urinary proteins were separated by immobilized pH gradient based on two-dimensional gel electrophoresis (2-DE). The silver-stained 2-DE gels were scanned with digital Image Scanner and analyzed with Image Master 2-DE Elite 3.01 software. Peptide mass fingerprint (PMF) of differential protein spots was obtained with MALDI-TOF-MS. Proteins were identified by Mascot software based on NCBI protein database. RESULTS: There were 66 spots with different expression of protein between SRNS children and SSNS children before steroid therapy, and 24 spots and 27 spots only occurred in SRNS children and SSNS children before steroid therapy, respectively. There were 75 spots with different expression of protein between SSNS children after steroid therapy and healthy controls, and 11 spots only occurred in SSNS children after steroid therapy. Eighteen protein spots with different expression (6 spots in each nephrotic group) were chose and analyzed by MALDI-TOF-MS, and 9 types of proteins were identified. CONCLUSIONS: Nine types of urinary proteins with different expression (6 spots in each nephrotic group) were identified between SRNS and SSNS children, and they might be the biomarkers for SRNS or SSNS.［Chin J Contemp Pediatr, 2009, 11 (5):341-345］
Primary nephrotic syndrome / Steroid resistance / Proteomics / Child
［1］易著文.实用小儿肾脏病手册［M］. 北京：人民卫生出版社, 2005, 326.
［2］李志辉，易著文，何小解，吴小川.激素耐药型和激素依赖型肾病患儿肾脏病理计量分析［J］.中华儿科杂志, 2001, 39(7):449-452.
［3］赵维玲,李志辉,易著文.儿童难治性肾病综合征小管间质损害的分析［J］.中国当代儿科杂志, 2000, 2(3):142-144.
［4］何威逊.有关难治性肾病诊断和治疗中的几个问题［J］.中华儿科杂志, 2000, 38(5):326-328.
［5］Norris JL, Cornett DS, Mobley JA, Andersson M, Seeley EH, Chaurand P, et al. Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis［J］. Int J Mass Spectrom, 2007, 260 (2-3):212-221.
［6］Dihazi H, Müller GA, Lindner S, Meyer M, Asif AR, Oellerich M, et al. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients［J］. Clin Chem, 2007, 53(9):1636-1645.
［7］中华医学会儿科学分会肾脏病学组.小儿肾小球疾病的临床分类、诊断及治疗［J］.中华儿科杂志, 2001, 12(39)：746-749.
［8］Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, et al. Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children［J］.Lancet, 1970, 1(7654):959-961.
［9］Behrman RE. Nelson Textbook of Pediatrics［M］. 16th ed. Philadephia: WB Sauders Co, 2000, 1500-1502.
［10］Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction ［J］.Circulation, 1996, 94(7):1506-1512.
［11］Rocha-Viegas L, Vicent GP, Baranao JL, Beato M, Pecci A. Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter［J］. Biol Chem, 2006, 281(45):33959-33970.
［12］Neuhaus TJ, Stallmach T, Genewein A. A boy with congenital analbu-minemia and steroid-sensitive idiopathic nephrotic syndrome: an experiment of nature ［J］. Eur Pediatr, 2008, 167(9):1073-1077.
［13］Ngai HH, Sit WH, Jiang PP, Thongboonkerd V, Wan JM. Markedly increased urinary preprohaptoglobin and haptoglobin in passive heymann nephritis: a differential proteomics approach［J］. Proteome Res, 2007, 6(8):3313-3320.
［14］Thongboonkerd V, Barati MT, McLeish KR, Benarafa C, RemoldO′Donnell E, Zheng S, et al. Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis［J］. Am Soc Nephrol, 2004, 15(3):650-662.
［15］Weber MH, Verwiebe R. Alpha 1-microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction ［J］. Eur Clin Chem Biochem, 1992, 30(10):683-691.
［16］Imai H, Wakui H, Ishino T, Komatsuda A, Nakamoto Y, Miuri AB, et al. Glomerular deposition of complex-forming glycoprotein heterogenous in charge (protein HC) in IgA nephropathy［J］. Clin Nephrol, 1992, 37(4):169-176.
［17］Wakui H, Kobayashi R, Itoh H, Imai H, Nakamoto Y, Miuri AB, et al. High-yield purification of the complex-forming glycoprotein in urine from normal and abnormal subjects［J］. Clin Chem, 1989, 35(4):577-581.
［18］黄艳军，黄松明，张爱华，费莉，徐颂周，陈荣华. 尿蛋白组学在儿童微小病变型肾病综合征中的初步研究［J］.中国现代医学杂志, 2006, 16(20):3152-3154.
